Invention Grant
- Patent Title: Immune regulation based on the depletion of CD69+ cells
- Patent Title (中): 基于CD69 +细胞消耗的免疫调节
-
Application No.: US10770639Application Date: 2004-02-02
-
Publication No.: US07867475B2Publication Date: 2011-01-11
- Inventor: Francisco Sanchez-Madrid , Carlos Martinez Alonso , David Sancho Madrid , Pablo Engel Rocamora , Enric Esplugues Artola , Javier Vega Ramos , Pilar Lauzurica Gómez
- Applicant: Francisco Sanchez-Madrid , Carlos Martinez Alonso , David Sancho Madrid , Pablo Engel Rocamora , Enric Esplugues Artola , Javier Vega Ramos , Pilar Lauzurica Gómez
- Applicant Address: ES Madrid ES Madrid ES Barcelona
- Assignee: Universidad Autonoma de Madrid,Consejo Superior de Investigaciones Cientificas,Pilar Lauzurica Gomóez
- Current Assignee: Universidad Autonoma de Madrid,Consejo Superior de Investigaciones Cientificas,Pilar Lauzurica Gomóez
- Current Assignee Address: ES Madrid ES Madrid ES Barcelona
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Agent Ivor R. Elrifi; Cynthia A. Kozakiewicz
- Main IPC: A61K51/00
- IPC: A61K51/00
Abstract:
Disclosed are methods of treating subjects having disorders or conditions characterized by an unwanted immune response including administering an effective amount of an early activation molecule agonist, antagonist or depletor, to the subject. Human monoclonal antibodies specific to the early activation molecules, and methods of use, are also disclosed.
Public/Granted literature
- US20050002929A1 Immune regulation based on the targeting of early activation molecules Public/Granted day:2005-01-06
Information query
